Skip to main contentSkip to navigation
Sirius Investors
Rosetta Genomics Ltd.

Rosetta Genomics Ltd.

ROSGQ
OTCHealthcare

ROSGQ Financial Statements & Analysis

Complete financial statements for ROSGQ including income statement, balance sheet, and cash flow statement. Analyze ROSGQ's revenue growth, profit margins, earnings trends, debt levels, and cash flow generation.

TTM figures are calculated by rolling up the last four quarterly filings (income and cash flow summed; balance sheet at period end).

Income Statement Comparison

Revenue & Net Income

Period Comparison

MetricTTM Q4 '16TTM Q2 '17ChangeImpact
Revenue7.23M5.49M24.0%
Gross Profit1.28M636.00K50.3%
Operating Income-15.53M-12.89M17.0%
Net Income-16.23M-14.27M12.1%
EPS-2.34-2.7216.3%
EBITDA-16.09M-13.46M16.4%
Gross Margin17.71%11.58%34.6%
Operating Margin-214.93%-234.75%9.2%
Net Income Margin-224.65%-259.73%15.6%
R&D Expenses3.16M2.79M11.6%

Income Statement Full Table

Free users can view the last 3 periods. Upgrade to see the full history.

Upgrade
MetricTTM Q2 '17TTM Q4 '16TTM Q3 '16TTM Q2 '16TTM Q1 '16
Revenue5.49M7.23M8.77M
Gross Profit636.00K1.28M2.99M
Operating Income-12.89M-15.53M-16.32M
Net Income-14.27M-16.23M-18.12M
EPS-2.72-2.34-2.81
EBITDA-13.46M-16.09M-15.53M
Gross Margin11.58%17.71%34.07%
Operating Margin-234.75%-214.93%-186.19%
Net Income Margin-259.73%-224.65%-206.70%
R&D Expenses2.79M3.16M3.35M

Our detailed financial analysis helps investors understand ROSGQ's business performance, operational efficiency, and financial health through comprehensive financial statement data presented in both quarterly and annual formats.

Track ROSGQ's financial performance metrics including revenue, gross profit, operating income, net income, total assets, liabilities, shareholders' equity, operating cash flow, and free cash flow with historical comparison and trend analysis.

Financial Metrics

Want to dive deeper into ROSGQ's financial health? Explore key financial metrics and ratios including profitability, liquidity, efficiency, and valuation metrics.

View Financial Metrics